Live news related to BIOMERIEUX stock (FR0013280286): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Lyon-based in vitro diagnostics specialist is among the most neglected values of the SBF 120 at mid-session this Monday. The stock is suffering fr…
The in vitro diagnostics group announces the creation of a new production unit in Isère for its Biofire PCR tests, with approximately 400 direct jobs …
Shares of the Lyon-based in vitro diagnostics specialist are regaining ground this Tuesday, May 12, moving against the trend of a declining SBF 120, w…
BioMérieux stock edges up 0.14% to €71.15 at midday this Thursday, May 7, in a nearly flat SBF 120 (-0.1%). The stock is attempting to consolidate aft…
The stock of the Lyon-based in vitro diagnostics specialist is regaining some ground this Thursday after a dismal week. Having recorded a new seven-ye…
The stock of the Lyon-based in vitro diagnostics specialist continues its downward spiral. In mid-afternoon on Wednesday, April 29, 2026, the stock fe…
BioMérieux's stock price has increased by 2.4% at the start of the week, reaching 72.65 euros during the session, after closing last Friday at 70.95 e…
Shares of the in vitro diagnostics specialist plummeted to 71.45 euros this Friday, down 2.46% from the previous day. The drop follows the announcemen…
On this Thursday, BioMérieux's stock experienced a sharp drop on Euronext Paris, falling nearly 17% to €73.75. The Lyon-based in vitro diagnostics com…
The in vitro diagnostics group bioMérieux has revised its annual targets downward following a first quarter impacted by weak respiratory epidemiology …
